
BioRestorative Therapies fell 5.5% from $1.11 to $1.05, behind the S&P 500's +5.7%. Its worst day was Feb 12 (−40.5%), and its low came Sep 3 at $0.14.
Nov 20, 2025 – Nov 20, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $-6.40 beat the $-7.40 estimate on $19,600.00 revenue (est. $170,000.00).
+0.4% · S&P 500 −1.7%
Story events cover the past 12 months · Times ET
EPS of $-2.40 beat the $-6.00 estimate on $23,170.00 revenue (est. $260,000.00).
+1.7% · S&P 500 −1.2%
BioRestorative Therapies closed at its lowest level of the year, 87.1% below where the year started.
−28.8% · S&P 500 +1.0%
Where it ended: a close of $1.05 on Nov 20, 2026. Up next: Q3 2026 earnings on Dec 1, 2026 (EPS est. $-2.60, revenue est. $90,000.00).
Nothing in the past 12 months.
All BRTX dividend historyReplay the year: the line draws itself and stops at each of the 3 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for BRTX and SPY from Benzinga historical bars. Not investment advice.